[
    {
        "id": "osp-2584",
        "type": "article-journal",
        "title": "A Rare Case of Metachronous Peripheral T-cell Non-Hodgkin Lymphoma Following Epstein-barr Virus-positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified",
        "author": [
            {
                "family": "Abraham",
                "given": "Latha"
            },
            {
                "family": "Paul",
                "given": "Mobin"
            },
            {
                "family": "P",
                "given": "Sophy M."
            },
            {
                "family": "Varghese",
                "given": "Dasary"
            },
            {
                "family": "D’Souza",
                "given": "Chryselle Olive"
            }
        ],
        "URL": "https://omanscience.com/en/articles/a-rare-case-of-metachronous-peripheral-t-cell-non-hodgkin-lymphoma-following-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-not-otherwise-specified",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2023
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2023.13",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "We report a case of an elderly male who presented with enlarged abdominal lymph nodes and was diagnosed as having Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified (EBV+ DLBCL, NOS). He was started on chemotherapy which had to be discontinued after three cycles due to the development of life-threatening pneumocystis carinii pneumonia and poor performance status. Within two years, the patient presented with features of relapse. A repeat histopathological examination of the lymph node showed features of peripheral T-cell lymphoma, NOS and the clonality was confirmed by T-cell receptor gamma chain rearrangement assay. More studies are needed to understand the association of EBV+ DLBCL, NOS with other lymphomas."
    }
]